SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense volatility and trading volume as community members debate whether the rally is a legitimate breakout driven by upcoming music festival partnerships or a manipulated pump-and-dump scheme. Investors remain sharply divided, with some highlighting the project's real-world event utility and future roadmap as catalysts for growth, while others express concerns over high wallet concentration and potential regulatory investigation.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is gaining significant traction as investors reconnect with its 2011 origin as the original parody token, with community members highlighting its deep historical roots, locked supply, and organic narrative as drivers for potential long-term growth. While some skeptics dismiss it as a joke, proponents are actively comparing it to early memecoin successes and emphasizing its status as a foundational piece of crypto culture that is currently undergoing a massive resurgence.

Aave is a decentralized money market protocol where users can lend and borrow cryptocurrency across 20 different assets as collateral. The protocol has a native token called AAVE, which is also a governance token that lets the community decide the direction of the protocol in a collective manner. Lenders can&nbsp;earn interest by providing liquidity to the market, while borrowers can borrow by collateralizing their cryptoassets to take out loans from the liquidity pools.

AAVE

AAVE is generating significant community buzz as traders weigh its potential as an undervalued DeFi leader against broader market volatility and governance-related news. While some participants are actively accumulating on dips in anticipation of a parabolic breakout, others remain focused on technical support levels and ongoing debates regarding its long-term stability compared to other lending protocols.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending due to a significant policy shift following a new executive order that accelerates FDA review pathways for psychedelic-based therapies, including LSD. Investors are actively debating the potential for a sector-wide re-rating and identifying candidates for future M&A, as Definium remains in focus with multiple Phase 3 trial readouts scheduled throughout the year.

Procure ETF Trust II - Procure Space ETF

The Procure Space ETF ($UFO) is attracting significant community attention as investors position themselves for the potential IPO of SpaceX and the broader expansion of the commercial space economy. While some community members appreciate the ETF for its broad exposure to industry leaders, others are debating whether its diverse holdings truly constitute a 'pure play' on space, leading to discussions about alternative investment strategies.

SuRo Capital Corp. operates as a publicly traded investment fund. It seeks to invest in a broad range of sectors and industries as well as to provide investors with access to such companies through its publicly traded common stock. The company was founded by Mark David Klein on September 17, 2010 and is headquartered in New York, NY.

SuRo Capital Corp

SuRo Capital Corp.

SuRo Capital is trending as investors focus on its concentrated stake in high-growth AI infrastructure companies like CoreWeave and OpenAI, with community sentiment bolstered by potential IPO activity and the firm's portfolio value relative to its NAV. Traders are actively discussing the stock's significant discount to underlying asset value and the impact of upcoming liquidity events, often drawing comparisons to other venture-focused investment vehicles.

iShares Trust - iShares MSCI United Kingdom ETF

iShares MSCI United Kingdom ETF

The iShares MSCI United Kingdom ETF is trending as investors monitor ongoing economic instability in the UK, including high inflation and fluctuating political leadership. The community is actively discussing the ETF as a proxy for UK market performance while debating the long-term impacts of fiscal policy and currency volatility on British equities.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is currently trending due to a wave of sector-wide optimism following a high-profile executive order to fast-track psychedelic research for conditions like PTSD and depression. Investors are actively discussing the potential for accelerated FDA approval timelines, while the community remains focused on the company's progress with its COMP360 therapy and the broader regulatory shift toward psychedelic-assisted treatments.

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Twist Bioscience Corp

Twist Bioscience is generating strong buzz as investors weigh its robust revenue growth and expanding market reach against skepticism regarding the firm's path to consistent profitability. The community is actively debating the company's long-term potential as a foundational "picks and shovels" provider for the biotechnology sector while closely monitoring insider trading activity and recent revenue guidance upgrades.

Tidal Trust II - Defiance Daily Target 2X Long IONQ ETF

Defiance Daily Target 2X Long IONQ ETF

IONX is trending as investors actively track its performance as a 2x leveraged play on IonQ, frequently debating its volatility and potential for significant gains against the underlying stock's technical movements. The community is focused on using this ETF for aggressive scalping and swing trading strategies, often weighing its rapid price fluctuations against the broader operational milestones and market outlook for the quantum computing sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Credit Acceptance (NASDAQ:CACC) Price Target Raised to $540.00 at Stephens

Stephens lifted their price objective on shares of Credit Acceptance from $450.00 to $540.00 and gave the company an "equal weight" rating in a research note on Friday...

CACC Crosses Above Average Analyst Target

In recent trading, shares of Credit Acceptance Corp (Symbol: CACC) have crossed above the average analyst 12-month target price of $475.50, changing hands for $489.84/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgra...

Credit Acceptance (NASDAQ:CACC) Share Price Crosses Above Two Hundred Day Moving Average - What's Next?

Credit Acceptance (NASDAQ:CACC) Stock Price Crosses Above Two Hundred Day Moving Average - What's Next...

Zacks Industry Outlook Highlights Credit Acceptance, Enova and Encore Capital 

Credit Acceptance, Enova and Encore Capital have been highlighted in this Industry Outlook article.


3 Consumer Loan Stocks That Could Win Big From Industry Tailwinds

While subdued asset quality and macro uncertainty are concerns, lower rates and easier lending criteria are expected to boost the Zacks Consumer Loans industry's prospects. So, firms like CACC, ENVA and ECPG are poised to gain.

Credit Acceptance Corporation $CACC Shares Sold by London Co. of Virginia

London Co. of Virginia cut its stake in Credit Acceptance Corporation (NASDAQ:CACC - Free Report) by 2.4% in the third quarter, according to the company in its most recent disclosure with the...

Beck Mack & Oliver LLC Decreases Holdings in Credit Acceptance Corporation $CACC

Beck Mack & Oliver LLC decreased its stake in Credit Acceptance Corporation (NASDAQ:CACC - Free Report) by 10.4% during the 3rd quarter, according to the company in its most recent disclosure with...

Credit Acceptance Is 'The Only Non-Prime Lender Worth Owning,' Citron Says

Citron Research calls Credit Acceptance ($CACC) the only non-prime lender worth owning, setting a $714 fair value target. Read the details.read more...

Credit Acceptance (NASDAQ:CACC) Stock Price Down 5.5% - Here's What Happened

Credit Acceptance (NASDAQ:CACC) Stock Price Down 5.5% - Here's Why...

Credit Acceptance (NASDAQ:CACC) Stock Price Passes Above 200-Day Moving Average - Time to Sell?

Credit Acceptance (NASDAQ:CACC) Stock Passes Above Two Hundred Day Moving Average - Here's What Happened...

Credit Acceptance Corp. engages in the provision of dealer financing programs that enables automobile dealers to sell vehicles to consumers, regardless of its credit history. Its financing programs are offered through a nationwide network of automobile dealers who benefit from sales of vehicles to consumers. The company was founded by Donald A. Foss in 1972 and is headquartered in Southfield, MI.

Current Price	$527.56
Prev Close	$494.56
Open	$509.99
Dividend Yield	0.00%
50-Day Moving Average	$474.02
Beta	1.31
Avg. Volume	228,195.09
PE Ratio	14.45

52-Week High	$549.75
52-Week Low	$401.90
Market Capitalization	$5.67B
EPS (Annual)	$36.38
Price to Book	3.70
Revenue Per Employee	$1M

CACC
Credit Acceptance Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CACC News

CACCCredit Acceptance Corp.